R&D | Cutting-edge science and innovative research

R&D

Partner Content

Innovation in Psychosis Therapeutics Summit

Join leaders at the Innovation in Psychosis Therapeutics Summit to revolutionize psychosis treatment

News

EMA panel endorses AI for MASH clinical trials

PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.

News

Building site with thre emen in high viz jackets and protective headweare

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

R&D

Partner Content

4th ALS Drug Development Summit

Join 200+ experts at the 4th ALS Summit to advance biomarkers, targets, and trials for ALS & FTD

R&D

Partner Content

London Biotechnology Show

London Biotechnology Show Levels Up with Industry Pioneers in Exhibitor Lineup, Hosted Buyer Programme

News

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

R&D

Partner Content

4th ALS Drug Development Summit

Join 200+ experts at the 4th ALS Summit to advance biomarkers, targets, and trials for ALS & FTD

R&D

Partner Content

London Biotechnology Show

London Biotechnology Show Levels Up with Industry Pioneers in Exhibitor Lineup, Hosted Buyer Programme

Debates & Insights

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

Sponsored

Synthetic control arms in clinical trials: Making it happen

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/live.png

Webinars

Sponsored

How synthetic control arms are changing clinical trials

Clinical trials are involved, expensive, and have been done largely the same way for decades but with today’s technology all that can change.

News

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

News

EMA panel endorses AI for MASH clinical trials

PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.

Press Releases

Views & Analysis

Touring Chiesi's vision for the future at the new Biotech Ce...

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure – black-painted and as yet under construction, gigantic cranes and all – th

News

Vir awarded $1 billion multi-year BARDA influenza contract

The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an

Views & Analysis

R&D

Building a regenerative medicine industry: Lessons from Nort...

The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions.

R&D

Defining success for early-stage, small biotech trials

Small biotech companies encounter significant challenges in designing and implementing clinical development programmes.

R&D

How Japan is pioneering the future of oncology clinical tria...

Discover how Japan is leading the way in oncology clinical trials through the implementation of decentralised clinical trials

Deep Dive

R&D

R&D Contraceptive pills condoms and intrauterine device

Research and Development

R&D

Deep Dive: Research and Development 2025

Every breakthrough in medicine, every new treatment that changes lives, starts with research.

R&D

Breaking through financial barriers to clinical trials: How ...

R&D

Sponsored

Exploring the future: Opportunities and challenges in cell a...

Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.

R&D

Sponsored

Beyond clinical: Boosting recruitment and retention with SDO...

The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.

R&D

evolution of clinical research in the UK

Sponsored

The evolution of clinical research: Embracing new delivery m...

The UK is welcoming a new era of clinical trial delivery, evolving beyond the traditional site-centric approach to also embrace remote, decentralised, virtual, and hybrid trials and enablin